Lighting the way in biotechnological progress

Nordberg Medical is a Swedish biotech company driven by purposeful innovation. We specialize in the development, manufacturing and commercialization of advanced medical biomaterials.

Science drives us, humanity defines us.

Transforming the field of bio-regeneration

By bridging nature and technology, we develop next-generation biomaterials that empower the body‘s natural regenerative potential. Driven by science, we challenge standards and transform the field of bio-regeneration – delivering regenerative solutions for aesthetic medicine and beyond. Passionate about uncovering the aging process and delivering life-changing solutions, we aim to provide a meaningful impact to the evolving field of regenerative aesthetics.

From scientific vision to therapeutic impact

Founded to challenge convention and elevate human potential, Nordberg Medical has grown into a biotech company with a global ambition in regenerative biomaterial innovation. From early scientific breakthroughs to the launch of JULÄINE™ of Sweden, every step reflects our purpose to restore, enhance, and elevate. Science drives us, but humanity defines us: we create high quality regenerative solutions that help people around the world rethink the way they age.

The Nordberg Medical Institute: Advancing excellence in aesthetics

Education advances. Experience evolves. Excellence transforms.

Integrity drives innovation

Excellence in medical aesthetics begins with scientific integrity. The Nordberg Medical Institute unites leading clinicians, researchers, and advisors to guide product development, clinical standards, and education.

Translating science into practice

Every Nordberg Medical solution is rooted in evidence and designed for real-world results. Research partnerships and structured training programs ensure that scientific advances become clinical advantages.

Empowering professional growth

In collaboration with key opinion leaders, we support aesthetic clinics with insights and services that elevate care and expand business potential. At Nordberg Medical, this model combines therapeutic excellence with long-term partnership.

Pioneering the future of regenerative science

Key moments defining our journey in science, growth and global impact.

2021

JULÄINE™ receives the CE Mark, establishing it as a certified regenerative collagen stimulating solution for professional use. Nordberg Medical achieves ISO 13485 certification, reinforcing our commitment to quality and trust. A major milestone in our pursuit of excellence: manufacturing operations begin at the first site in Sweden.

2022

We expand our commercial footprint across Europe and open a regional office in Hong Kong. A second manufacturing site is established in Sweden, strengthening our production capacity and global reach. This year marks a step forward in our international presence.

2023

We develop our first whitepaper in partnership with the Research Institute of Sweden, reflecting our evidence-driven approach to bio-regeneration. A scientific collaboration with the Karolinska Institute further anchors our innovation in academic excellence. Research and credibility remain central to our growth.

2024

LASYNPRO™, our proprietary bio-activation technology, is officially trademarked. JULÄINE™ is introduced to the European aesthetic community at a launch event in Spain. Our biomaterials platform continues to evolve with purpose and precision.

2025

Our Swedish manufacturing site is approved for the Brazilian market, advancing our regulatory journey. JULÄINE™ launches across Central Europe, Italy, and the Nordics, with FDA registration in progress for its future launch in the USA. Scientific integrity and global ambition guide every milestone.

Coming soon

Over 30 clinical studies are currently in development, each shaping the future of regenerative aesthetics. As we expand into Indonesia, Poland and the GCC, our vision of changing the way we age continues to reach new frontiers.

Our leadership: leading minds in scientific innovation

Vision. Precision. Experience that leads.

At the helm of Nordberg Medical is a team of proven leaders in biotechnology, medicine and regenerative science. Their combined experience ensures quality, responsibility and trust. Future-oriented, they are passionate about progress and further expansion to meet the needs of a diversifying society.

Our leadership: leading minds in scientific innovation

Vision. Precision. Experience that leads.

Meet the leadership team advancing regenerative innovation

01 | 05

Jack Yu, PhD

Chief Executive Officer

Dr. Yu brings over 25 years of experience in the pharma and medical device sectors across Europe, the USA, and Asia. With a PhD in Neuroscience from Uppsala University and an EMBA from Copenhagen Business School, his leadership is grounded in scientific excellence and global business acumen.

Garth Reynolds

Chief Operating Officer

Mr. Reynolds began his career with ANZ Banking Group in New Zealand and advanced through roles in investment banking, venture capital, and private equity in London. His strategic leadership has driven transformative changes across various industries, expanding product portfolios and guiding companies into new markets.

Silvia Alexandra Fernandes

Chief Quality & Regulatory Officer

Ms. Fernandes has over 18 years of experience overseeing quality and regulatory departments in the medical device and pharmaceutical sectors. Holding a master's degree in Microbiology and Environmental Engineering, she advocates for a quality mindset that transcends departmental boundaries, embedding it throughout the organization.

Jonas Lejontand

Chief Human Resources Officer

Mr. Lejontand possesses more than two decades of HR experience in the pharmaceutical industry. He has served as VP HR for Recipharm, leading global HR functions, and has managed various HR projects through his consultancy. He holds a Bachelor's degree in Human Resource Management from Uppsala University.

David Tepper

Chief Financial Officer

With over 19 years of experience, David Tepper has held key roles in both dynamic startup environments and established institutions like hospitals. He has extensive experience in board assignments for different companies & associations. David’s focus area is combining strategic financial leadership with a strong focus on growth and operational development, always under the motto "strategic financial thinking as the engine of accelerated growth".

Recognised standards of excellence

As a globally oriented biotech company, Nordberg Medical holds internationally respected certifications that reflect our commitment to quality, safety, and regulatory excellence. Our CE-marked biomaterials meet the requirements of European health, safety, and environmental protection legislation, ensuring every product is clinically validated for professional use.

We operate under ISO 13485:2016, the global standard for quality management systems in medical devices, covering everything from product design to post-market surveillance.

These certifications are more than credentials — they embody Nordberg Medical’s unwavering commitment to excellence, authenticity, and trust.